Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maternal PHiD-CV vaccination to prevent infant acute lower respiratory infection
ACTRN12618000150246Phase 3Completed
- Sponsor
- Menzies School of Health Research
- Start
- Jan 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
Phase 3, randomised, single-blind trial of pneumococcal polysaccharide conjugate vaccine 10-valent adsorbed in pulmonary infection (2 arms), sponsored by Menzies School of Health Research. Primary endpoint: Incidence rate of medically attended acute lower respiratory infection in infants. Started Jan 2019; status: completed.
02
Drugs
pneumococcal polysaccharide conjugate vaccine 10-valent adsorbed
03
Conditions
pulmonary infection
Beyond the preview
Go deeper on ACTRN12618000150246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000150246.